Are new antiretroviral treatments increasing the risks of clinical obesity?-Reference-Cited by-同舟云学术

Are new antiretroviral treatments increasing the risks of clinical obesity?

Published:2019-01 Issue:1 Volume:5 Page:41-43
ISSN:2055-6640
Container-title:Journal of Virus Eradication
language:en
Short-container-title:Journal of Virus Eradication

Author:

Hill Andrew,Waters Laura,Pozniak Anton

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Epidemiology

Reference21 articles.

1. Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada;Koethe;AIDS Res Hum Retroviruses,2016

2. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK;Bhaskaran;Lancet Diabetes Endocrinol,2018

3. Weight change after antiretroviral therapy and mortality;Yuh;Clin Infect Dis,2015

4. World Health Organization. Overweight and obesity, key facts. Available at:www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (accessed January 2019).

5. Dolutegravir and weight gain: an unexpected bothering side-effect;Menard;AIDS,2017

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Complications Associated with Use of Integrase Strand Transfer Inhibitors (InSTI) for the Treatment of HIV-1 Infection: Focus on Weight Changes, Lipids, Glucose and Bone Metabolism;Current HIV/AIDS Reports;2024-08-29

2. Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda;AIDS Research and Therapy;2024-04-18

3. Re-evaluating the relationship between youth with HIV and BMI in an age of increasing rates of overweight and obese youth;BMC Research Notes;2024-04-01

4. Efficacy, safety, and tolerability of dolutegravir-based ART regimen in Durban, South Africa: a cohort study;BMC Infectious Diseases;2024-03-21

5. Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis;PLOS ONE;2024-01-29